DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Advancing Equity in Rare Healthcare
The National Organization for Rare Disorders (NORD®), in collaboration with the Rare Disease Diversity Coalition (RDDC), is pleased to announce the second webinar in a three-part series on health equity and rare disorders. This webinar will focus on the role health care providers and health systems play in promoting diversity, equity and inclusion (DEI) in healthcare settings.
Experts will share perspectives and approaches for improving healthcare provider-patient interactions and strengthening infrastructure and systems to support DEI efforts.
NORD will be giving away three Rare Disease Day swag boxes to help you #ShowYourStripes. The drawing will be on February 14 at 5:00pm ET so be sure to register ahead of time in order to be eligible.
Date & Time:
Wednesday, February 23, 2022
02:00 PM ET
This event has ended.


Related Content
-
News & MeetingsEarly, Effective Control of Graves’ Disease Improves Survival, Regardless of TreatmentAn early and intensive control of hypert...
-
Evidence & EducationCancer Mortality Following Treatment for Adult HyperthyroidismContext: High-dose iodine 131 is the tr...
-
Evidence & EducationRisk Factors of Hepatic Dysfunction in Patients With Graves’ Hyperthyroidism and the Efficacy of 131iodine Tre...Hepatic dysfunction is often observed in...
-
Evidence & EducationThyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients With HyperthyroidismObjective: The purpose of this study wa...
-
Evidence & EducationGraves’ Disease and Pregnancy PlanningBoth hypothyroidism and hyperthyroidism ...
-
Evidence & EducationCombination Treatment With T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?Context: Levothyroxine therapy is the t...
-
Evidence & EducationHyperthyroid Patients Without Graves’ Orbitopathy are not at Increased Risk of Developing Glaucoma: A Nationwi...Purpose: Graves' disease (GD) and toxic...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.